UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027723 |
|---|---|
| Receipt number | R000031764 |
| Scientific Title | Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriers |
| Date of disclosure of the study information | 2017/09/01 |
| Last modified on | 2017/06/12 11:35:11 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Acronym
Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Scientific Title
Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Scientific Title:Acronym
Risk-Reducing salpingo-oophorectomy in BRCA1/2 mutant carriers
Region
| Japan |
Condition
Condition
BRCA1/2 mutant carriers
Classification by specialty
| Surgery in general | Endocrine surgery | Breast surgery |
| Obstetrics and Gynecology | Operative medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the safety and efficacy of risk reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutant carriers
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The safety and efficacy of risk reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutnat carriers
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Maneuver |
Interventions/Control_1
Risk-reducing salpingo-oophorectomy (RRSO)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
1)BRCA1/2 mutant carriers
2)prefer not to pregnant women
3)Performance Status: 0-1
4)informed consent
Key exclusion criteria
pregnant woman or possibility for pregnant women
Target sample size
3
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Taisuke Mori |
Organization
Kyoto Prefectural University of Medicine
Division name
Department of Obstetrics and Gynecology
Zip code
Address
465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan
TEL
075-251-5560
moriman@koto.kpu-m.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Taisuke Mori |
Organization
Kyoto Prefectural University of Medicine
Division name
Department of Obstetrics and Gynecology
Zip code
Address
465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan
TEL
075-251-5560
Homepage URL
moriman@koto.kpu-m.ac.jp
Sponsor or person
Institute
Kyoto Prefectural University of Medicine
Institute
Department
Personal name
Funding Source
Organization
Kyoto Prefectural University of Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 09 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2017 | Year | 08 | Month | 31 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 09 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 06 | Month | 12 | Day |
Last modified on
| 2017 | Year | 06 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031764
